Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Smaller and earlier trials reported reductions in colonic transit time and improvements in functional gastrointestinal symptoms
Key things to know: its temporary through Dec 31, 2027, requires Part D enrollment + prior auth, and single-dose vials/pens of Zepbound arent included
People who are eligible to receive GLP-1 medications under the program will have a $50 copay
[1] [2] Referral to a dietitian is particularly valuable if you are uncertain about appropriate portion sizes, meal planning, or how to structure a balanced reduced-calorie diet
Novo Nordisk's patent for Saxenda expires later this year, and rivals Teva, Pfizer and Mylan are all expected to launch generic versions of liraglutide later in 2024
Dosage is introduced gradually to minimize side effects and support comfort
